Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Riley Ennis"'
Autor:
Nathan Wan, David Weinberg, Tzu-Yu Liu, Katherine Niehaus, Eric A. Ariazi, Daniel Delubac, Ajay Kannan, Brandon White, Mitch Bailey, Marvin Bertin, Nathan Boley, Derek Bowen, James Cregg, Adam M. Drake, Riley Ennis, Signe Fransen, Erik Gafni, Loren Hansen, Yaping Liu, Gabriel L. Otte, Jennifer Pecson, Brandon Rice, Gabriel E. Sanderson, Aarushi Sharma, John St. John, Catherina Tang, Abraham Tzou, Leilani Young, Girish Putcha, Imran S. Haque
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
Abstract Background Blood-based methods using cell-free DNA (cfDNA) are under development as an alternative to existing screening tests. However, early-stage detection of cancer using tumor-derived cfDNA has proven challenging because of the small pr
Externí odkaz:
https://doaj.org/article/fe732f6285b646618c64630c5a91ae05
Autor:
Zachary R. Chalmers, Caitlin F. Connelly, David Fabrizio, Laurie Gay, Siraj M. Ali, Riley Ennis, Alexa Schrock, Brittany Campbell, Adam Shlien, Juliann Chmielecki, Franklin Huang, Yuting He, James Sun, Uri Tabori, Mark Kennedy, Daniel S. Lieber, Steven Roels, Jared White, Geoffrey A. Otto, Jeffrey S. Ross, Levi Garraway, Vincent A. Miller, Phillip J. Stephens, Garrett M. Frampton
Publikováno v:
Genome Medicine, Vol 9, Iss 1, Pp 1-14 (2017)
Abstract Background High tumor mutational burden (TMB) is an emerging biomarker of sensitivity to immune checkpoint inhibitors and has been shown to be more significantly associated with response to PD-1 and PD-L1 blockade immunotherapy than PD-1 or
Externí odkaz:
https://doaj.org/article/fb907a4b3aaf43769173e9ac0018e2eb
Autor:
Abraham Tzou, Jennifer Pecson, Tzu-Yu Liu, Signe Fransen, John St. John, David E. Weinberg, Riley Ennis, Yaping Liu, Brandon J. Rice, Daniel Delubac, Nathan Boley, Marvin Bertin, Katherine E. Niehaus, Leilani Young, Aarushi Sharma, Girish Putcha, Adam Drake, James Cregg, Erik Gafni, Nathan Wan, Catherina Tang, Derek Bowen, Brandon White, Imran S. Haque, Ajay Kannan, Mitch Bailey, Gabriel E. Sanderson, Eric A. Ariazi, Gabriel Otte, Loren Hansen
Publikováno v:
BMC Cancer
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
BMC Cancer, Vol 19, Iss 1, Pp 1-10 (2019)
BackgroundBlood-based methods using cell-free DNA (cfDNA) are under development as an alternative to existing screening tests. However, early-stage detection of cancer using tumor-derived cfDNA has proven challenging because of the small proportion o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5ac7ac8fea1c37b4c91bf798c0a4eff
https://pubmed.ncbi.nlm.nih.gov/31443703
https://pubmed.ncbi.nlm.nih.gov/31443703
Autor:
Krishnan K. Palaniappan, Mitch Bailey, David E. Weinberg, Tzu-Yu Liu, Anne-Marie Martin, Nancy Krunic, C. Jimmy Lin, Peter Ulz, Irving Wang, Hayley Warsinske, Riley Ennis, Francesco Vallania, Karen Assayag
Publikováno v:
Cancer Research. 80:2433-2433
Blood-based markers can be used to non-invasively predict cancer progression after treatment. Here, cell-free DNA (cfDNA) and plasma proteins were evaluated to explore biological signatures of progression in non-small cell lung cancer (NSCLC). Baseli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d55a8fed912b46a3aaccd4a4dbfee9e
https://doi.org/10.1158/1538-7445.am2020-2433
https://doi.org/10.1158/1538-7445.am2020-2433
Autor:
Riley Ennis, Franklin W. Huang, Uri Tabori, Mark Kennedy, Jared White, Brittany Campbell, Caitlin F. Connelly, Siraj M. Ali, Alexa B. Schrock, Steven Roels, James Sun, David Fabrizio, Jeffrey S. Ross, Phillip J. Stephens, Daniel S. Lieber, Yuting He, Vincent A. Miller, Juliann Chmielecki, Levi A. Garraway, Garrett M. Frampton, Zachary R. Chalmers, Adam Shlien, G. Otto
Publikováno v:
Genome Medicine
Genome Medicine, Vol 9, Iss 1, Pp 1-14 (2017)
Genome Medicine, Vol 9, Iss 1, Pp 1-14 (2017)
Background High tumor mutational burden (TMB) is an emerging biomarker of sensitivity to immune checkpoint inhibitors and has been shown to be more significantly associated with response to PD-1 and PD-L1 blockade immunotherapy than PD-1 or PD-L1 exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c61698cc007ed55a692049362bb8d874
https://doi.org/10.1186/s13073-017-0424-2
https://doi.org/10.1186/s13073-017-0424-2
Autor:
Gabriel Otte, Mitch Bailey, Marvin Bertin, Signe Fransen, Tzu-Yu Liu, Loren Hansen, Catherina Tang, Gabriel E. Sanderson, Katherine E. Niehaus, Abe Tzou, Brandon White, Aarushi Sharma, Ajay Kannan, Riley Ennis, Yaping Liu, Erik Gafni, David H. Weinberg, James Cregg, Nathan Wan, Nathan Boley, Girish Putcha, Derek Bowen, Eric A. Ariazi, Imran S. Haque, Jennifer Pecson, John St. John, Brandon J. Rice, Leilani Young, Daniel Delubac, Adam Drake
Publikováno v:
Gastroenterology. 156:S-600
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ba4940ae445effb5471db4266a9e069
https://doi.org/10.1016/s0016-5085(19)38396-9
https://doi.org/10.1016/s0016-5085(19)38396-9
Autor:
Vincent A. Miller, Xingyi Guo, Garrett M. Frampton, Riley Ennis, Justin M M Cates, James Sun, Siraj M. Ali, Igor Puzanov, Harlan Robins, David Fabrizio, Justin M. Balko, Zachary R. Chalmers, Erik Yusko, Dennie T. Frederick, Jeffrey A. Sosman, Jeffrey S. Ross, Joel R. Greenbowe, Yu Shyr, Sohail Balasubramanian, Yaomin Xu, Philip J. Stephens, Christine M. Lovly, Matthew J. Rioth, Catherine Sanders, Douglas B. Johnson, Yuting He, Ryan J. Sullivan
Therapeutic antibodies blocking programmed death-1 and its ligand (PD-1/PD-L1) induce durable responses in a substantial fraction of melanoma patients. We sought to determine whether the number and/or type of mutations identified using a next-generat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6f9a586bb821609540c8078d5e8bf45
https://europepmc.org/articles/PMC5134329/
https://europepmc.org/articles/PMC5134329/
Autor:
Eric A. Ariazi, Gabriel Otte, Singer Michael, Jonathan Berliner, John Dulin, Riley Ennis, David H. Weinberg, Adam Drake, Girish Putcha, Brandon White, Imran S. Haque, Abraham Tzou, Jennifer Pecson, Daniel Delubac, Aarushi Sharma, Jill Waters, Corey Schaninger, Katherine E. Niehaus, Erik Gafni
Publikováno v:
Cancer Research. 78:2227-2227
Introduction: Blood-based tests hold great promise as cancer diagnostics but until now have largely been restricted to the analysis of a single class of molecules (eg, circulating tumor DNA, platelet mRNA, circulating proteins). The ability to analyz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d8b66c02b392b656b0c456e0621bc53
https://doi.org/10.1158/1538-7445.am2018-2227
https://doi.org/10.1158/1538-7445.am2018-2227
Autor:
Riley Ennis, Philip J. Stephens, Doron Lipson, Garrett M. Frampton, Roman Yelensky, Zachary R. Chalmers
Publikováno v:
Cancer Research. 76:2629-2629
INTRODUCTION Tumor mutation load is a biomarker of emerging significance in cancer immunotherapy. Both mutation load and neoantigen load, as measured by whole exome sequencing, have been shown, in several tumor types, to correlate with patient respon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c974d31f49ee9278cbb4ad75fa9b44dd
https://doi.org/10.1158/1538-7445.am2016-2629
https://doi.org/10.1158/1538-7445.am2016-2629
Autor:
Jihye Kim, Ilya G. Serebriiskii, Garrett M. Frampton, Mark Bailey, Aik Choon Tan, Erica A. Golemis, Joshua E. Meyer, Riley Ennis, Christopher H. Lieu
Publikováno v:
Journal of Clinical Oncology. 34:3574-3574
3574Background: Rectal cancer is increasing in incidence in young patients, with emerging data demonstrating differences when compared to colon cancer in tumor biology. Additional data demonstrate ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d752c99f69a763ae835e4ddfd3368e2
https://doi.org/10.1200/jco.2016.34.15_suppl.3574
https://doi.org/10.1200/jco.2016.34.15_suppl.3574